Education
About Us
Working with TipRanks
Follow Us
Selvita SA (DE:787)
:787
787 Stock Chart & Stats
Day’s Range― - ―
52-Week Range€6.18 - €14.14
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€162.49M
Enterprise Value€913.64M
Total Cash (Recent Filing)€22.51M
Total Debt (Recent Filing)€218.54M
Price to Earnings (P/E)1642.3
Beta0.63
Next Earnings
Nov 20, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.06
Shares Outstanding18,355,474
10 Day Avg. Volume2
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€9.37Price Target Upside9.72% Upside
Rating ConsensusHold
Number of Analyst Covering0
787 FAQ
What was Selvita SA’s price range in the past 12 months?
Selvita SA lowest stock price was €6.18 and its highest was €14.14 in the past 12 months.
What is Selvita SA’s market cap?
Selvita SA’s market cap is €162.49M.
When is Selvita SA’s upcoming earnings report date?
Selvita SA’s upcoming earnings report date is Nov 20, 2025 which is in 51 days.
How were Selvita SA’s earnings last quarter?
Selvita SA released its earnings results on Sep 18, 2025. The company reported -€0.059 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.059.
Is Selvita SA overvalued?
According to Wall Street analysts Selvita SA’s price is currently Undervalued.
Does Selvita SA pay dividends?
Selvita SA does not currently pay dividends.
What is Selvita SA’s EPS estimate?
Selvita SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Selvita SA have?
Selvita SA has 18,355,474 shares outstanding.
What happened to Selvita SA’s price movement after its last earnings report?
Selvita SA reported an EPS of -€0.059 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 4.935%.
Which hedge fund is a major shareholder of Selvita SA?
Currently, no hedge funds are holding shares in DE:787
Company Description
Selvita SA
Selvita S.A. operates as a contract research organization in Poland, rest of Europe, the United States, and internationally. It operates in two segments, Contract Research Organization (CRO) services, and Bioinformatics. The company offers drug discovery services in the areas of assay development and screening, medicinal and synthetic chemistry, computer-aided drug design/ artificial intelligence, structural biology, in vitro/ In Vivo pharmacology, ADME/DMPK and analytical testing. It also provides pharma services in the field of drug testing and bioanalytical analysis, including development and optimization, validation and transfer, stability studies, quality control, and regulatory aspects support services. In addition, the company offers research and development services in the areas of process research, laboratory scale custom synthesis of NCEs, industrial chemistry, and synthesis of isotopically labelled compounds, as well as other services for the agrochemical industry. Further, it provides bio-data science and advanced software services to data-driven life science and healthcare organizations. Selvita S.A. was founded in 2007 and is headquartered in Krakow, Poland.
Technical Analysis
Options Prices
Currently, No data available
---